TransAct Technologies Incorporated (TACT)


TransAct Technologies Incorporated is a common stock listing on NASDAQ for a technology hardware company focused on transaction-based and specialty printing systems. The company designs, develops, and markets thermal printers and related terminals used to produce labels, coupons, receipts, tickets, and other transaction records in the United States and international markets. Its product and service mix also includes POS receipt paper, ribbons, replacement parts, accessories, maintenance and repair services, and technical support. TransAct additionally provides EPICENTRAL print system software for casino operators, along with the BOHA! terminal, a device that combines hardware and software features such as a touchscreen, operating system, and thermal print mechanisms. The company sells through OEMs, value-added resellers, distributors, direct channels, and its webstore, and markets products under the TransAct, BOHA!, AccuDate, Epic, Ithaca, and EPICENTRAL brands. Incorporated in 1996, it is headquartered in Hamden, Connecticut.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-TACT
$4.34
-16.5% Downside
Fair
$7
34.6% Upside
Undervalued
Good
0.0%
August 12, 2026
-108.4x
1.7x
1.0x
53.231 M
40.959 M
10.7%
61.6%
4.1
-1,360.9%
Valuation • Fair Value

TransAct Technologies Incorporated (NASDAQ-TACT) Fair Value by Valuation Model

Compare the primary fair value estimate for TransAct Technologies Incorporated (NASDAQ-TACT) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$4.34

Estimated downside of 16.5% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$3.81

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$5

Earnings power value estimate.

Comps Fair Value

$4.59

Comparable-company valuation reference.

Analyst Price Target

$7

Analysts imply upside of 34.6%.

How to read these valuation models

Use this section to compare the primary fair value estimate for TransAct Technologies Incorporated (NASDAQ-TACT) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for TransAct Technologies Incorporated (NASDAQ-TACT)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

52.842 M

Current operating scale indicator.

Revenue Forecast

55.5 M

Forward revenue estimate.

EBITDA

28 K

Current operating profitability reference.

EBITDA Forecast

1.3 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review TransAct Technologies Incorporated (NASDAQ-TACT) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for TransAct Technologies Incorporated (NASDAQ-TACT)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.85

No elevated caution signal from this screen.

Altman Z-Score

4.1

Relatively strong balance-sheet zone.

FCF / Net Income

-1,360.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for TransAct Technologies Incorporated (NASDAQ-TACT). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for TransAct Technologies Incorporated (NASDAQ-TACT)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 12, 2026

Days to Earnings

22

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for TransAct Technologies Incorporated (NASDAQ-TACT), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

TransAct Technologies Incorporated (NASDAQ-TACT) Stock Forecast & Technical Outlook

Review TransAct Technologies Incorporated (NASDAQ-TACT) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for TransAct Technologies Incorporated (NASDAQ-TACT) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Buy

The 1-hour technical read for TransAct Technologies Incorporated (NASDAQ-TACT) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for TransAct Technologies Incorporated (NASDAQ-TACT) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for TransAct Technologies Incorporated (NASDAQ-TACT) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for TransAct Technologies Incorporated (NASDAQ-TACT) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for TransAct Technologies Incorporated (NASDAQ-TACT)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for TransAct Technologies Incorporated (NASDAQ-TACT) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ Fast Investor Answers

TransAct Technologies Incorporated (NASDAQ-TACT) Stock FAQ

Quick answers about TransAct Technologies Incorporated (NASDAQ-TACT) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$4.34
Estimated downside 16.5%
Valuation Rating
Overvalued
Estimated downside of 16.5%
Analyst Target
$7
Implied upside 34.6%
Financial Health
Good
Current financial-health read

The current fair value estimate for TransAct Technologies Incorporated (NASDAQ-TACT) is $4.34. This implies an estimated downside of 16.5% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 16.5% versus the current market price.

The available analyst price target for TransAct Technologies Incorporated (NASDAQ-TACT) is $7. The analyst target implies estimated upside of 34.6%.

The current financial health read for TransAct Technologies Incorporated (NASDAQ-TACT) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for TransAct Technologies Incorporated (NASDAQ-TACT) is August 12, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for TransAct Technologies Incorporated (NASDAQ-TACT) is -108.4x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for TransAct Technologies Incorporated is 53.231 M.

The current enterprise value listed for TransAct Technologies Incorporated is 40.959 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for TransAct Technologies Incorporated is NASDAQ-TACT, and the stock is listed on NASDAQ.

TransAct Technologies Incorporated (NASDAQ-TACT) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for TransAct Technologies Incorporated is 10.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for TransAct Technologies Incorporated is 61.6%. Free float helps investors understand how much of the share base is available for public trading.